PPARG and diabetes mellitus: The antidiabetic thiazolidinediones (TZDs) are PPAR-γ activator drugs which selective PPARγ ligands, enhance the actions of insulin in peripheral tissues, used in the treatment of type 2 diabetes mellitus to improve target cell insulin sensitivity.